CTRI/2014/03/004489招募中未知
A RANDOMIZED DOUBLE-BLIND STUDY TO COMPARE EFFICACY OF MIFEPRISTONE AND MISOPROSTOL VERSUS MISOPROSTOL ALONE FOR INDUCTION OF LABOUR IN INTRAUTERINE FOETAL DEATH.
RS MEDICAL COLLEGE KOLKATA0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women with period of gestation >20 weeks presenting with dead fetus as confirmed by ultrasonography without clinical evidence of active labour, bleeding per vagina, or ruptured membranes were included.
排除标准
- •Women who had known allergy to mifepristone and misoprostol or had contraindications for the use of two drugs were excluded.
- •b. Women with known previous transmural uterine incision (caeserian section, myomectomy), with grand multiparity ( > 4 ,with Haemoglobin level below 8 gm/dl or with any medical problem as renal, liver, cardiovascular diseases or coagulopathy were also excluded.
- •c. Women who had low lying placenta as demonstrated by ultrasonography and who showed evidence of infection, who were in active labour or had bleeding or leaking per vagina were not included.
研究者
相似试验
已完成
不适用
RANDOMIZED DOUBLE-BLIND STUDY ON THE EFFICACY AND SAFETY OF BMS - 207147 IN RELATION TO FLUCONAZOLE IN THE TREATMENT OF IMMUNOCOMPROMISED PATIENTS WITH ESOPHAGEAL CANDIDIASISPER-019-00BRISTOL MYERS SQUIBB PERU S.A.,
已完成
不适用
A CLINICAL STUDY TO ASSESS THE EFFICACY OF ORELVO (VOCLOSPORIN) COMPARED WITH PLACEBO IN ACHIEVING RENAL RESPONSE AFTER 24 WEEKS OF THERAPY IN SUBJECTS WITH ACTIVE LUPUS NEPHRITIS (LN)-M321 Systemic lupus erythematosus with organ or system involvementSystemic lupus erythematosus with organ or system involvementM321PER-023-17Aurinia Pharmaceutical Inc.,19
进行中（未招募）
不适用
STUDY TO ASSESS THE EFFICACY OF BF2.649 IN THE TREATMENT OF NARCOLEPTIC PATIENTS WITH RESIDUAL EXCESSIVE DAYTIME SLEEPINESS.arcolepsyMedDRA version: 15.1Level: LLTClassification code 10048322Term: Narcolepsy aggravatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 15.1Level: PTClassification code 10028713Term: NarcolepsySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 15.1Level: PTClassification code 10007737Term: CataplexySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 15.1Level: LLTClassification code 10048323Term: Cataplexy aggravatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 15.1Level: LLTClassification code 10028715Term: Narcolepsy with cataplexySystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-000084-27-DEBioprojet50
进行中（未招募）
不适用
DOUBLE BLIND RANDOMIZED STUDY TO ASSESS THE EFFICACY OF BF2.649 COMPARED TO PLACEBO IN ADD-ON TO SODIUM OXYBATE IN THE TREATMENT OF NARCOLEPTIC PATIENTS WITH RESIDUAL EXCESSIVE DAYTIME SLEEPINESS (EDS) DURING 8 WEEKS.arcolepsyMedDRA version: 14.1Level: LLTClassification code 10048322Term: Narcolepsy aggravatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: PTClassification code 10028713Term: NarcolepsySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: PTClassification code 10007737Term: CataplexySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: LLTClassification code 10048323Term: Cataplexy aggravatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 15.0Level: LLTClassification code 10028715Term: Narcolepsy with cataplexySystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-000084-27-ESBioprojet60
进行中（未招募）
不适用
STUDY TO ASSESS THE EFFICACY OF BF2.649 IN THE TREATMENT OF NARCOLEPTIC PATIENTS WITH RESIDUAL EXCESSIVE DAYTIME SLEEPINESS.EUCTR2011-000084-27-FIBioprojet50